Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Assessing SU-011248 in Previously Untreated Patients With Advanced Urothelial Cancer Ineligible for Cisplatin-Based Chemotherapy

NCT01118039 is registered in ClinicalTrials.gov with Hospital del Mar as lead sponsor.

NCT NCT01118039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Assessing SU-011248 in Previously Untreated Patients With Advanced Urothelial Cancer Ineligible for Cisplatin-Based Chemotherapy
Lead sponsor
Hospital del Mar
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2006
Completion date
Not reported
Enrollment
41 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, transitional cell cancer of the renal pelvis and ureter, urethral cancer